Retroviruses use a cellular tRNA molecule as primer for reverse transcription. The complementarity between the 3h end of this tRNA and a sequence near the 5h end of the viral RNA, the primer-binding site (PBS), allows the primer to anneal onto the viral RNA. During reverse transcription 18 nucleotides of the tRNA primer are copied into the viral cDNA, thereby regenerating the PBS sequence of the progeny. Thus, the PBS sequence reveals which primer was used. Human immunodeficiency viruses are known to replicate efficiently with tRNA Lys3 as primer. Examination of the PBS sequence in natural and laboratory isolates indicates that a variant tRNA Lys is occasionally used as primer. This variant, for which the murine genomic sequence was described previously, was termed tRNA Lys5 and differs from tRNA Lys3 at five nucleotide positions. These results suggest that HIV uses both tRNA Lys3 and tRNA Lys5 molecules as primer, causing a switch of the PBS sequence.
Retroviruses use a cellular tRNA molecule as primer for reverse transcription. The complementarity between the 3h end of this tRNA and a sequence near the 5h end of the viral RNA, the primer-binding site (PBS), allows the primer to anneal onto the viral RNA. During reverse transcription 18 nucleotides of the tRNA primer are copied into the viral cDNA, thereby regenerating the PBS sequence of the progeny. Thus, the PBS sequence reveals which primer was used. Human immunodeficiency viruses are known to replicate efficiently with tRNA Lys3 as primer. Examination of the PBS sequence in natural and laboratory isolates indicates that a variant tRNA Lys is occasionally used as primer. This variant, for which the murine genomic sequence was described previously, was termed tRNA Lys5 and differs from tRNA Lys3 at five nucleotide positions. These results suggest that HIV uses both tRNA Lys3 and tRNA Lys5 molecules as primer, causing a switch of the PBS sequence.
The replication cycle of retroviruses involves reverse transcription of the viral RNA genome into a double-stranded DNA, which is integrated into the host-cell genome (reviewed by Varmus & Swanstrom, 1984) . This process is mediated by the virion-associated enzyme reverse transcriptase (RT) and a cellular tRNA is used as primer. This tRNA binds with its 3h-terminal 18 nucleotides to a complementary sequence in the viral genome, referred to as the primer-binding site (PBS). Apart from the complementarity between the PBS and tRNA sequences, additional basepairing interactions between the tRNA primer and vRNA template may support this binding (Isel et al., 1995 ; Berkhout & Schoneveld, 1993 ; Aiyar et al., 1994) . Furthermore, binding of the tRNA primer onto the Author for correspondence : Ben Berkhout Fax j31 20 6916531. e-mail B.Berkhout!AMC.UVA.NL vRNA can be activated by RT and nucleocapsid (NC) protein (Araya et al., 1979 ; Prats et al., 1988 ; Barat et al., 1989 ; Li et al., 1996) . The RT protein, or the precursor Gag-Pol protein, was also suggested to be involved in selective encapsidation of the tRNA primer into virions (Peters & Hu, 1980 ; Levin & Seidman, 1981 ; Mak et al., 1994) .
The human immunodeficiency viruses (HIV-1 and HIV-2) and all simian immunodeficiency viruses efficiently replicate with tRNA Lys$ as primer. By mutating the PBS sequence, we and others (Li et al., 1994 ; Wakefield et al., 1995) recently demonstrated that HIV-1 can replicate with other tRNA primers (tRNA Ile , tRNA His , tRNA Lys",# , tRNA Phe , tRNA Pro , tRNA Trp ), although less efficiently compared with the natural tRNA Lys$ primer. These mutants are unstable and revert to the wild-type PBS Lys$ sequence upon prolonged culturing . This reversion is mediated by annealing of a wild-type tRNA Lys$ onto the mutant PBS sequence, followed by copying of the 18 nucleotides at the 3h terminus of this tRNA primer during reverse transcription. During this mutation\reversion analysis, we occasionally observed a variant PBS sequence with a single C U substitution in the centre of the motif (Fig. 1) . This suggests the presence of a variant tRNA primer resembling tRNA Lys$ in human cells. The PBS point mutation corresponds with a G A substitution at position 69 in the tRNA acceptor-stem (Fig. 2) . A mouse gene encoding such a putative tRNA Lys species was previously described (Han & Harding, 1983) . This murine tRNA contains five nucleotide differences compared with the human tRNA Lys$ sequence (positions 4, 15, 17, 48 and 69). We arbitrarily refer to this tRNA as tRNA Lys& (Fig. 2) . The PBS Lys& sequence was also observed in other mutation\reversion studies (Vicenzi et al., 1994 ; A. T. Das and others, unpublished) .
Alignment of the PBS region of natural HIV-1 and HIV-2 isolates demonstrates considerable sequence variation up-and downstream of the PBS sequence, but relatively little variation is observed in the 18 nt PBS sequence ( Fig. 3 ; Myers et al., 1994) . Three out of the 24 sequenced HIV-2 isolates, but none of the 30 sequenced HIV-1 isolates, have a PBS Lys& sequence. We tested the stability of the PBS Lys& sequence in the HIV-2 0001-4426 # 1997 SGM Fig. 1 . Primer-binding sites in HIV. PBS sequences (lower lines) complementary to tRNA Lys3 and tRNA Lys5 (upper lines) are found in HIV-1 and HIV-2 viruses, both natural isolates (Fig. 3) and viruses obtained in mutation/reversion studies. Nucleotides in the PBS Lys5 /tRNA Lys5 duplex that differ from the PBS Lys3 /tRNA Lys3 duplex are marked by a shaded box. Other PBS sequences that are not perfectly complementary to either tRNA Lys3 or tRNA Lys5 are not shown (n l 2 for HIV-1 natural isolates, n l 4 for HIV-2 natural isolates, n l 3 for HIV-1 laboratory isolates). These variants may have resulted from PCR or sequencing errors. a, Combined results of studies in which the PBS site , the R-U5 region (A. T. Das and others, unpublished) and the U5 region (Vicenzi et al., 1994) were mutated. (Han & Harding, 1983) , tRNA Lys3 , tRNA Lys1 and tRNA Lys2 are shown. tRNA Lys4 (not shown) is a tRNA Lys form specific for transformed cells that was initially thought to be an undermodified tRNA Lys2 (Raba et al., 1979) , but turned out to be a differentially modified form of tRNA Lys2 (Hayenga et al., 1986) . Nucleotides differing from tRNA Lys3 are shaded. Base modifications are indicated according to standard nomenclature (Sprinzl et al., 1989) isolate ROD (Peden & Martin, 1996) . SupT1 T cells were transfected with the pROD10 proviral clone and cultured for 2 weeks as previously described . The viruscontaining culture supernatant was used to infect fresh cells, which were cultured for another week. To determine the PBS sequence of the viral progeny, the LTR-leader region of the proviral DNA was amplified from total cellular DNA by PCR and cloned as described . Four clones were sequenced and all contained a PBS sequence complementary to tRNA Lys$ instead of tRNA Lys& , indicating that the PBS Lys& sequence is not stably maintained in the HIV-2 isolate. These combined results suggest that the variant tRNA Lys& molecule is used at a low frequency (approximately 3 %, Fig. 1 ) in reverse transcription by the HIV virus.
There are several possible explanations for the infrequent use of tRNA Lys& as primer in HIV replication. First and most importantly, this tRNA species may represent a so-called minor tRNA. Indeed, tRNA Lys& is not one of the three major tRNA Lys species identified in rabbit liver (tRNA Lys" , tRNA Lys# , tRNA Lys$ ; Raba et al., 1979) , and it is also not one of the four major tRNA species identified in HIV-1 virions (tRNA Lys" , tRNA Lys# , tRNA Lys$ , tRNA Ile ; Jiang et al., 1993) . Alternatively, inefficient packaging of tRNA Lys& may result in a low concentration of this tRNA species in virions, and thus in an infrequent priming with this tRNA during HIV replication. We note that the tRNA Lys" and tRNA Lys# variants, which have 15 and 13 base changes compared with tRNA Lys$ , are packaged into HIV-1 virions (Jiang et al., 1993) . Differences tRNA primers in HIV replication tRNA primers in HIV replication Fig. 3 . PBS sequences of HIV-1 and HIV-2 isolates. The PBS sequences of HIV-1 and HIV-2 isolates are grouped according to the different subtypes (Myers et al., 1994) . =, deleted nucleotide ; X, insertion of ACTTGACGGTAATAGG (in the HIV-1 IBNG isolate). Three of the HIV-2 isolates have a deletion of one G-nucleotide in the PBS sequence. This may indicate that yet another tRNA Lys variant with a deletion of one C-nucleotide was used as primer for reverse transcription.
in PBS-annealing efficiency may also result in reduced tRNA Lys& usage. tRNA Lys$ and tRNA Lys& differ at five nucleotide positions (Fig. 2) . The putative additional tRNAvRNA contacts involving the anticodon loop (Isel et al., 1995) will not be different for these two tRNA species, but one of the nucleotide changes (at position 69) affects the basepairing between the tRNA and the PBS (Fig. 1) . At this position, tRNA Lys$ can form a G-C basepair with PBS Lys$ and a G-U basepair with PBS Lys& . In contrast, tRNA Lys& forms an A-U basepair with PBS Lys& and an A-C mismatch with PBS Lys$ . Thus, annealing of tRNA Lys$ may be more efficient, resulting in the accumulation of PBS Lys$ sites. Finally, the more frequent tRNA Lys$ usage may result from a more efficient priming by the HIV-1 RT enzyme. We note that this initiation reaction is rather specific because the related tRNA Lys" and tRNA Lys# primers are not efficiently used by the HIV-1 enzyme (Oude Essink et al., 1996) . Consistent with this result, spontaneous PBS Lys",# variation is never observed (Figs 1 and 3) . Concluding, the occurrence of a PBS Lys& sequence in HIV retroviruses suggests that a tRNA Lys& molecule is present in human cells. This minor tRNA Lys& species may play a specialized role in the metabolism of the host cell, but there is currently no evidence for a specific role of this variant tRNA primer in HIV biology.
